Xolair and Oxycontin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Xolair (omalizumab) and Oxycontin (oxycodone hydrochloride). Common drug interactions include impaired gastric emptying among females and drug withdrawal syndrome among males.
The phase IV clinical study analyzes what interactions people have when they take Xolair and Oxycontin. It is created by eHealthMe based on reports of 76 people who take the same drugs from the FDA, and is updated regularly.
What is Xolair?
Xolair has active ingredients of omalizumab. It is often used in asthma. eHealthMe is studying from 77,555 Xolair users. Check the latest studies of Xolair.
What is Oxycontin?
Oxycontin has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 212,533 Oxycontin users. Check the latest studies of Oxycontin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
76 people who take Xolair and Oxycontin together, and have interactions are studied.

What are the common drug interactions of Xolair and Oxycontin, by gender? *:
female:
- Impaired gastric emptying
- Loss of consciousness
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Pain in extremity
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Renal failure acute (rapid kidney dysfunction)
- Secretion discharge
- Swelling face
- Wheezing (a high-pitched whistling sound made while you breath)
- Aphasia (damage to the parts of the brain that control language)
male:
- Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- C-reactive protein increased
- Dyspnoea (difficult or laboured respiration)
- Forced expiratory volume decreased (decreased lung expired air volume)
- General physical health deterioration (weak health status)
- Headache (pain in head)
- Hypertension (high blood pressure)
- Inflammation
- Injected limb mobility decreased
What are the common drug interactions of Xolair and Oxycontin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Respiratory tract inflammation
- Blood alkaline phosphatase increased
- C-reactive protein increased
- Dyspnoea (difficult or laboured respiration)
- Fatigue (feeling of tiredness)
- Forced expiratory volume decreased (decreased lung expired air volume)
- General physical health deterioration (weak health status)
- Headache (pain in head)
- Hypertension (high blood pressure)
- Inflammation
40-49:
- Blood pressure increased
- Headache (pain in head)
- Injection site erythema (redness at injection site)
- Lower respiratory tract infection
- Lymphadenopathy (disease or enlargement of lymph nodes)
- Nausea (feeling of having an urge to vomit)
- Cough
- Sputum discoloured
- Pneumonia
- Asthenia (weakness)
50-59:
- Aphasia (damage to the parts of the brain that control language)
- Breakthrough pain
- Cardiac disorder
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Chest pain
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
- Decreased appetite
- Depression
- Dysarthria (speech disorder)
- Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)
60+:
- Blood pressure increased
- Pyrexia (fever)
- Myalgia (muscle pain)
- Nasopharyngitis (inflammation of the nasopharynx)
- Red cell distribution width increased
- Seasonal allergy (allergic condition due to certain season)
- Stress
- Vomiting
- Weight decreased
- Dyspnoea (difficult or laboured respiration)
What are the existing conditions these people have? *
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 7.89%
- Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 5.26%
- Anaemia (lack of blood): 4 people, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Xolair and Oxycontin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Xolair and Oxycontin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Xolair:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Oxycontin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Xolair and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Oxycontin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on omalizumab and oxycodone hydrochloride (the active ingredients of Xolair and Oxycontin, respectively), and Xolair and Oxycontin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Fentora cause Joint Pain? - now
- Could Losartan cause Pelvic Inflammatory Disease? - 4 seconds ago
- Could Humalog cause Circulatory Collapse? - 7 seconds ago
- Could Losartan cause Dyspnea At Rest? - 7 seconds ago
- Could Daptomycin cause Escherichia Infection? - 18 seconds ago
- Could Ketoconazole cause Renal Mass? - 25 seconds ago
- Acromegaly and Tooth Disorder - 26 seconds ago
- Could Cabergoline cause Appetite - Increased? - 28 seconds ago
- Acromegaly and Social Avoidant Behavior - 28 seconds ago
- Drug interactions of Macrobid and Lysine - 28 seconds ago